Related Experiment Video

Updated: Aug 20, 2025

Real-Time Impedance-based Cell Analyzer as a Tool to Delineate Molecular Pathways Involved in Neurotoxicity and Neuroprotection in a Neuronal Cell Line
08:23

Real-Time Impedance-based Cell Analyzer as a Tool to Delineate Molecular Pathways Involved in Neurotoxicity and Neuroprotection in a Neuronal Cell Line

Published on: August 9, 2014

11.5K

Axi-cel in LBCL: fulfill two needs with one deed

Nilanjan Ghosh

    Blood
    |November 24, 2022
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Examining BCL-2 Family Function with Large Unilamellar Vesicles
    08:35

    Examining BCL-2 Family Function with Large Unilamellar Vesicles

    Published on: October 5, 2012

    8.0K
    Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
    14:20

    Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

    Published on: June 13, 2014

    16.8K

    Related Experiment Videos

    Last Updated: Aug 20, 2025

    Real-Time Impedance-based Cell Analyzer as a Tool to Delineate Molecular Pathways Involved in Neurotoxicity and Neuroprotection in a Neuronal Cell Line
    08:23

    Real-Time Impedance-based Cell Analyzer as a Tool to Delineate Molecular Pathways Involved in Neurotoxicity and Neuroprotection in a Neuronal Cell Line

    Published on: August 9, 2014

    11.5K
    Examining BCL-2 Family Function with Large Unilamellar Vesicles
    08:35

    Examining BCL-2 Family Function with Large Unilamellar Vesicles

    Published on: October 5, 2012

    8.0K
    Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
    14:20

    Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

    Published on: June 13, 2014

    16.8K

    Related Concept Videos

    Combination Therapies and Personalized Medicine02:50

    Combination Therapies and Personalized Medicine

    5.0K
    Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
    The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
    5.0K
    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    7.8K
    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against...
    7.8K

    Articles linked to this work by shared authors, journal, and citation graph.

    A Randomized Phase II Study of Subcutaneous Mosunetuzumab in Combination With Polatuzumab Vedotin Compared With Rituximab Plus Polatuzumab Vedotin in Patients With Relapsed or Refractory Large B-Cell Lymphoma.

    American journal of hematology·2026

    Mantle cell lymphoma outcomes following sequential first-line bendamustine-rituximab and second-line Bruton's tyrosine kinase inhibitor therapy.

    Blood cancer journal·2026

    Mosunetuzumab plus polatuzumab vedotin in relapsed/refractory MCL after BTK inhibitor therapy: a phase 2 study.

    Blood·2026

    Benefit of rituximab maintenance after first-line bendamustine-rituximab in patients with mantle cell lymphoma.

    Blood advances·2026

    Treatment-related outcomes and patterns of relapse in secondary CNS involvement by large B-cell lymphoma.

    Blood·2026

    Benefit of rituximab maintenance after first-line bendamustine-rituximab in patients with mantle cell lymphoma.

    Blood advances·2025

    Anti-αvβ3 antibodies in FNAIT are associated with disturbed angiogenesis and intracranial hemorrhage in men and mice.

    Blood·2026

    Factor VIII Aurora: A Naturally Occurring Gain of Function FVIII Variant with Enhanced FIXa Affinity.

    Blood·2026

    Gut Microbiota Drives Aging-related Erythropoiesis Impairment via Phenylacetic Acid-induced Histone Phenylacetylation.

    Blood·2026

    Neutrophils as chameleons of tissue inflammation and host-pathogen interactions.

    Blood·2026

    The CYB5R3 T117S Missense Variant is Associated with Attenuated Riociguat Efficacy in Sickle Cell Disease.

    Blood·2026

    Rapid Peak Cilta-cel Expansion is Associated with Delayed Neurotoxicity in Multiple Myeloma.

    Blood·2026

    ZrO₂@C-based colorimetric/photothermal dual-mode immunosensor coupled with a novel monoclonal antibody for quantification of Aspergillus ochraceus biomass.

    Food chemistry·2026

    A nitrogen-doped carbon quantum dots fluoroprobe for sequential detection of Hg<sup>2+</sup> and biologically important biothiols: Its practical applications in biological, food and environmental samples.

    Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2026

    A Chemical and Biological Portable Mass Spectrometer (CB-pMS) with Automated Sampling and Hybrid Ionization for Online Detection of Bioaerosols and VOCs.

    Analytical chemistry·2026

    Design and Development of Solvent-Sensitive Zn(II)/Al(III) Responsive Chemosensor: Extension to the Real-World Application.

    ChemPlusChem·2026

    Bifunctional Bile Acid-Salicylaldehyde Based Fluorescent Probe for Excellent Detection of Hydrazine and pH, and Multiple Applications in Environmental Samples, Smartphone-Assisted System, Paper Strips, and Living Cells.

    Luminescence : the journal of biological and chemical luminescence·2026

    Mismatch-Enhanced Specific PCR (MES-PCR): A Rapid and Cost-Effective Method for Screening CRISPR/Cas9-Induced Mutations.

    Biology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us